Cargando…
Proof of Principle that Molecular Modeling Followed by a Biophysical Experiment Can Develop Small Molecules that Restore Function to the Cardiac Thin Filament in the Presence of Cardiomyopathic Mutations
[Image: see text] This article reports a coupled computational experimental approach to design small molecules aimed at targeting genetic cardiomyopathies. We begin with a fully atomistic model of the cardiac thin filament. To this we dock molecules using accepted computational drug binding methodol...
Autores principales: | Szatkowski, Lukasz, Lynn, Melissa L., Holeman, Teryn, Williams, Michael R., Baldo, Anthony P., Tardiff, Jil C., Schwartz, Steven D. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Chemical Society
2019
|
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6649307/ https://www.ncbi.nlm.nih.gov/pubmed/31342001 http://dx.doi.org/10.1021/acsomega.8b03340 |
Ejemplares similares
-
Computational and biophysical determination of pathogenicity of variants of unknown significance in cardiac thin filament
por: Mason, Allison B., et al.
Publicado: (2021) -
Biophysics of the failing heart: physics and biology of heart muscle
por: Solaro, R, et al.
Publicado: (2013) -
Thin filament cardiomyopathies: A review of genetics, disease mechanisms, and emerging therapeutics
por: Keyt, Lucas K., et al.
Publicado: (2022) -
Clinical Phenotype and Outcome of Hypertrophic Cardiomyopathy Associated With Thin-Filament Gene Mutations
por: Coppini, Raffaele, et al.
Publicado: (2014) -
The effect of myosin RLC phosphorylation in normal and cardiomyopathic mouse hearts
por: Muthu, Priya, et al.
Publicado: (2012)